David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), sold 12,146 shares at $11.13 ($135K) on 2021-01-05, disclosed to the SEC on 2021-01-07.
Open-market sale of $135k FLXN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.13 | 6,073 | $68K | 50.0% |
| 2 | $11.13 | 6,073 | $68K | 50.0% |
| Total | $11.13 avg | 12,146 | $135K | 100% |
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2020-05-11 | $26K | — | Filing → |